Effect of the poly-ICLC vaccine adjuvant on prostate cancer patients’ PBMC

ABSTRACT: Identify PBMC RNA quantities whose level might predict response to prostate HIT-IT treatment Phase I Peripheral Blood Mononuclear Cell from 12 high risk prostate cancer patients

ORGANISM(S): Homo sapiens

PROVIDER: GSE294391 | GEO | 2026/04/10

REPOSITORIES: GEO